Tornado diagram of incremental per-member per-month costs (MYR) after increasing uptake of renin-angiotensin system inhibitor drugs.
<p>Tornado diagram of incremental per-member per-month costs (MYR) after increasing uptake of renin-angiotensin system inhibitor drugs.</p
Medicine, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Virology, Computational Biology, healthcare payer perspective, kidney disease, MYR, RAS drugs, Year 1, Year 5., drug acquisition costs, Conclusion Mild impact, budget impact analysis, renin-angiotensin system inhibitors drugs, PMPM, Malaysian population Introduction Renin-angiotensin system inhibitors
DOI identifier: 10.1371/journal.pone.0212832.g003
Sorry, we are unable to provide the full text but you may find it at the